Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Delhi HC allows Intas to sell cancer drug Bevatas, sets aside order favouring Sun Pharma
The Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medication, Bevatas, to the market. This decision overturns a previous block on the drug, affirming the court's view that Bevatas and Sun Pharma's Bevetex are sufficiently different in their ingredients and intended use.
Sun Pharma Share Price Live Updates: Sun Pharma's Weekly Returns Dip by 2.46%
Stocks to buy today: Sudeep Pharma, Rubicon Research, ICICI Prudential AMC
Stocks to buy today: Aakash Shah of Choice Broking has recommended buying three stocks today - Rubicon Research, Sudeep Pharma, and ICICI Prudential Asset Management.
Sun Pharma Share Price Live Updates: Sun Pharma's Price and Trend Overview
Reliance operationalises clean energy giga complex; elevates national exchequer contribution to Rs 2,16,472 crore in FY26
Reliance Industries has launched its clean energy operations. The company commissioned solar module manufacturing and began advanced work on a battery storage giga-factory. Reliance also significantly increased its contributions to the national exchequer. Jio Platforms accelerated its research and development, filing numerous new patents. The company is focused on enabling India's energy and digital future.
True North buys 25% stake in pharma co Embio
Private equity firm True North is investing approximately $50 million in Embio Ltd. Embio manufactures Active Pharmaceutical Ingredients for regulated markets. This investment will support Embio's research and development and capacity expansion. It will also help scale their contract development and manufacturing business. Embio specializes in complex APIs and synthetic biology.
Sensex falls 70 points, Nifty below 23,900 as US-Iran tensions simmer
Indian stock markets opened lower on Wednesday. Sensex and Nifty saw minor declines. Investors are watching US strikes on Iran and their effect on peace deal hopes. Broader markets are performing better. India VIX, a volatility measure, dropped. Top Sensex losers included HDFC Bank and Infosys. Sun Pharma shares led gains. Midcap and smallcap indices saw small gains.
Stocks to Watch today: Coal India, PhysicsWallah, ONGC, Siemens, IRCTC
Stocks to Watch today, May 27, 2026: MobiKwik, Sun Pharma, J&K Tyre, and Elgi Equipments are among some of the top stocks to remain in focus during today's trading session
Indices trade near flat line in early trade; breadth strong
Media, metal and PSU Bank shares advanced while consumer durables, FMCG and pharma shares declined.
Sun Pharma shares slip post Q4; analysts cautious on near-term upside
In the March quarter, Sun Pharma reported net profit at ₹2,714 crore, as compared to ₹2,150 crore a year ago, up 26.2 per cent year-on-year (Y-o-Y)
Margin pressure, slower growth outlook may cap upside for Sun Pharma stock
Sun Pharma reported strong revenue and profit growth in the March quarter, but EBITDA margins faced pressure from increased investments and lower milestone income. The company anticipates range-bound margins and moderating revenue growth in FY27, driven by specialty launches and R&D spending. Domestic formulations remain robust, while US segment recovery is expected to be gradual.
Sun Pharma Shares In Focus As Motilal Oswal Retains Bullish Call After Q4 — Check Target Price, Upside
Sun Pharma delivered in-line revenue in Q4, whereas Ebitda/PAT came in lower than expected, dragged down by higher marketing spending and lower milestone income.